Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIVING: Genetics and Anticoagulants
NCT01627665Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dabigatran etexilate oral solution, rivaroxaban in thromboembolism, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2011; status: completed.
02
Drugs
dabigatran etexilate oral solutionrivaroxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT01627665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627665.